IPSC
Century Therapeutics, Inc.Company with tickers: IPSC
CIK
1850119
CUSIP
15673T100
Shares Outstanding
180,354,809
13F Activity (30d)
71 filings
71 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $23,684,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | — | ||||
| Operating Income | $-23,684,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-21,645,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |